MediciNova announced development progress on intranasal formulation of SARS-CoV-2 vaccine for COVID-19
On Sept. 1, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
Amyris scaled first fermentation-based cannabinoid
On Sept. 1, 2020, Amyris announced that it had successfully scaled up the commercial production of Cannabigerol (CBG)…
Arcadia Biosciences acquired proprietary hemp varieties with acquisition of Industrial Seed Innovations
On Sept. 1, 2020, Arcadia Biosciences announced it had completed the purchase of Oregon-based Industrial Seed Innovations (ISI)…
Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
Roche received FDA approval for first HIV-1/HIV-2 Qualitative test on the cobas 6800/8800 Systems in the fight against HIV/AIDS
On Sept. 1, 2020, Roche announced FDA approval for the cobasﾮ HIV-1/HIV-2 Qualitative Test for use on the…
Sanofi updated Kevzara (sarilumab) phase 3 trial in severe and critically ill COVID-19 patients outside the US
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
HDT BIO received NIH contract to advance novel RNA/LIONﾙ COVID-19 vaccine into clinical trials
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
COVID-19 | Disease | FDA | Therapeutics
City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
National Wastewater Surveillance System launched to detect antimicrobial resistance and COVID-19
In September 2020, the Centers for Disease Control and Prevention (CDC) announced the launch of the National Wastewater…
Atossa Therapeutics announced positive safety assessment in clinical study of COVID-19 AT-301 nasal spray
On Sept. 1, 2020, Atossa Therapeutics announced a positive interim safety assessment from the first cohort of healthy…
UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
Disease | NIH | Therapeutics
NIAID awarded BioCryst $44 million contract to advance development of galidesivir
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
Scientists used genomics to discover an ancient dog species that may teach us about human vocalization
On Aug. 31, 2020, in a study published in PNAS, researchers used conservation biology and genomics to discover…
Development of COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial across all adult age groups
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
Biotechnology | Diagnostics | Disease | NIH
New gene associated with reduced risk for cirrhosis
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
Philips EV300 ventilator supply contract with US Department of Health and Human Services to end
On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
Gileadﾒs investigational antiviral Vekluryﾮ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
Assembly Biosciences and Arbutus announced collaboration to evaluate combination of core inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in patients with Chronic Hepatitis B Virus Infection
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…